03. 14. 2023

Protocol Design and Investigator Site Selection: Type 2 Diabetes Mellitus (T2DM)

Read more
03. 14. 2023

Protocol Design, Country and Investigator Site Selection: NSCLC

Read more
03. 14. 2023

Protocol Optimization and Study Feasibility: Iron Overload Integrated Development Plan, Phase 1B Trial

Read more
03. 14. 2023

Protocol Planning: Inotuzumab Ozogamicin In Acute Lymphoblastic Leukemia (ALL)

Read more